- Home
- AZZ vs LNTH Comparison
AZZ vs LNTH Comparison
Compare AZZ & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZZ
- LNTH
- Stock Information
- Founded
- AZZ 1956
- LNTH 1956
- Country
- AZZ United States
- LNTH United States
- Employees
- AZZ N/A
- LNTH N/A
- Industry
- AZZ Industrial Specialties
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AZZ Industrials
- LNTH Health Care
- Exchange
- AZZ Nasdaq
- LNTH Nasdaq
- Market Cap
- AZZ 3.3B
- LNTH 3.6B
- IPO Year
- AZZ N/A
- LNTH 2015
- Fundamental
- Price
- AZZ $107.00
- LNTH $52.70
- Analyst Decision
- AZZ Buy
- LNTH Strong Buy
- Analyst Count
- AZZ 6
- LNTH 6
- Target Price
- AZZ $114.50
- LNTH $85.50
- AVG Volume (30 Days)
- AZZ 249.7K
- LNTH 1.4M
- Earning Date
- AZZ 10-08-2025
- LNTH 11-05-2025
- Dividend Yield
- AZZ 0.64%
- LNTH N/A
- EPS Growth
- AZZ 908.98
- LNTH N/A
- EPS
- AZZ 8.62
- LNTH 3.77
- Revenue
- AZZ $1,586,498,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- AZZ $6.86
- LNTH N/A
- Revenue Next Year
- AZZ $4.21
- LNTH $3.24
- P/E Ratio
- AZZ $12.40
- LNTH $13.97
- Revenue Growth
- AZZ 1.70
- LNTH 5.75
- 52 Week Low
- AZZ $70.90
- LNTH $47.25
- 52 Week High
- AZZ $119.95
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- AZZ 35.34
- LNTH 46.96
- Support Level
- AZZ $107.57
- LNTH $49.75
- Resistance Level
- AZZ $110.32
- LNTH $53.97
- Average True Range (ATR)
- AZZ 2.65
- LNTH 1.52
- MACD
- AZZ -0.79
- LNTH 0.60
- Stochastic Oscillator
- AZZ 1.72
- LNTH 62.98
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.